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Research
Evidence suggests that prenatal and early-
life exposure to pesticides may be causative 
factors in a variety of human disorders. For 
example, a meta-analysis by Wigle et al. 
(2009) showed that maternally exposed off-
spring have increased risk of childhood leu-
kemia [odds ratio = 2.64; 95% confidence 
interval (CI), 1.4–5].
There are also indications that reproductive 
abnormalities, expressed as cryptorchidism, 
hypospadias, and decreased penile length, may 
be linked to pesticide exposure, most strik-
ingly in maternally exposed boys (Andersen 
et al. 2008; Damgaard et al. 2006; Rocheleau 
et al. 2009). This is significant because male 
fertility is thought to be declining in many 
countries (Andersson et al. 2008), and peri-
natal hypospadias/cryptorchidism are risk fac-
tors for reduced sperm quality and testicular 
cancer in adulthood (Skakkebaek et al. 2001). 
Banned persistent organochlorines [p,p´-DDT 
(1,1,1-trichloro-2-[o-chlorophenyl]-2,2-[p-
chlorophenyl]ethane), p,p´-DDE (p,p´-1,1-
bis-(4-chlorophenyl)-2,2-dichloroethene), 
β-hexachloro cyclo hexane, hexachloro benzene, 
α-endosulfan, cis-heptachloro epoxide, oxy-
chlordane, dieldrin] were detected in all sam-
ples of breast milk in a case–control study of 
mothers in Denmark and Finland. Also, lev-
els were significantly higher in samples from 
mothers of sons with cryptorchidism than in 
samples from matched controls (1997–2001; 
Damgaard et al. 2006). Female Danish green-
house workers exposed to current-use pesti-
cides were more likely to give birth to a son 
with cryptorchidism than were a random 
sample of mothers from the Copenhagen area 
(6.2% and 1.9%). Furthermore, sons of moth-
ers who directly handled treated plants or were 
engaged in spraying pesticides had significantly 
smaller penises than did sons of mothers who 
had non contact roles in the greenhouse indus-
try (Andersen et al. 2008). Last, in a recent 
meta-analysis of studies from the United States 
and Europe, Rocheleau et al. (2009) reported 
that maternal occupational exposure to pesti-
cides was associated with a 36% increased risk 
of hypospadias relative to the risk in mothers 
without exposure (risk ratio = 1.36; 95% CI, 
1.04–1.77). The risk of developing cryp-
torchidism (Pierik et al. 2004) and hypospa-
dias (Brouwers et al. 2007) was also associated 
with paternal exposures to pesticides, mainly in 
greenhouses for the production of vegetables 
and flowers.
The term “testicular dysgenesis syn-
drome” (TDS) has been proposed to explain 
the inter related nature of these abnormalities 
(Skakkebaek et al. 2001). It is conceivable 
that estrogenic and/or anti androgenic con-
taminants play a role in TDS. Experimental 
studies with rats have shown that maternal 
exposure to flutamide (a pharmaceutical anti-
androgen) affects androgen-dependent devel-
opmental outcomes such as ano genital 
distance and nipple retention (McIntyre et al. 
2001). However, ethinyl estradiol has not been 
shown to affect these end points (Howdeshell 
et al. 2008). Furthermore, hormone receptor 
screening in vitro suggests a preponderance of 
anti androgenic activity compared with estro-
genic activity in non organochlorine (current-
use) pesticides. For example, Kojima et al. 
(2004) screened 161 pesticides and reported 
that 52 were anti androgenic, whereas only 
29 were estrogenic, and Orton et al. (2009) 
reported that 6 of 12 pesticides screened were 
anti androgenic and none were estrogenic. 
There is a good correlation between andro-
gen receptor (AR) antagonist properties and 
in vivo anti androgenic effects, and there is also 
good evidence that androgen-sensitive end 
points are demasculinized in male rats when 
exposed in utero to a wide range of pesticides. 
Antiandrogenic effects both in vitro and via 
maternal exposure in vivo have been reported 
in response to the herbicide linuron (Gray 
et al. 1999; Lambright et al. 2000); the fun-
gicides prochloraz (Vinggaard et al. 2005), 
procymidone (Ostby et al. 1999), tebucon-
azole (Taxvig et al. 2007), and vinclozolin 
(Anway et al. 2006; Uzumcu et al. 2004); the 
organochlorine insecticides DDE (Gray et al. 
1999) and endosulfan (Sinha et al. 2001); 
the organophosphate dimethoate (Verma and 
Mohanty 2009); and the pyrethroid insecticide 
deltamethrin (Andrade et al. 2002). However, 
with the exception of linuron, dimethoate, 
deltamethrin, and tebuconazole, the pesti-
cides listed above have not been authorized for 
use in Europe during the past 5 years, which 
should result in lower occupational, residen-
tial, and dietary exposures. Endocrine-relevant 
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Background: Evidence suggests that there is widespread decline in male reproductive health and 
that anti androgenic pollutants may play a significant role. There is also a clear disparity between pes-
ticide exposure and data on endocrine disruption, with most of the published literature focused on 
pesticides that are no longer registered for use in developed countries.
oBjective: We used estimated human exposure data to select pesticides to test for anti androgenic 
activity, focusing on highest use pesticides.
Methods: We used European databases to select 134 candidate pesticides based on highest expo-
sure, followed by a filtering step according to known or predicted receptor-mediated anti androgenic 
potency, based on a previously published quantitative structure–activity relationship (QSAR) 
model. In total, 37 pesticides were tested for in vitro androgen receptor (AR) antagonism. Of these, 
14 were previously reported to be AR antagonists (“active”), 4 were predicted AR antagonists using 
the QSAR, 6 were predicted to not be AR antagonists (“inactive”), and 13 had unknown activity, 
which were “out of domain” and therefore could not be classified with the QSAR (“unknown”).
results: All 14 pesticides with previous evidence of AR antagonism were confirmed as anti-
androgenic in our assay, and 9 previously untested pesticides were identified as anti androgenic 
(dimethomorph, fenhexamid, quinoxyfen, cyprodinil, λ-cyhalothrin, pyrimethanil, fludioxonil, 
azinphos-methyl, pirimiphos-methyl). In addition, we classified 7 compounds as androgenic.
conclusions: Due to estimated anti androgenic potency, current use, estimated exposure, and lack 
of previous data, we strongly recommend that dimethomorph, fludioxonil, fenhexamid, imazalil, 
ortho-phenylphenol, and pirimiphos-methyl be tested for anti androgenic effects in vivo. The lack of 
human biomonitoring data for environmentally relevant pesticides presents a barrier to current risk 
assessment of pesticides on humans.
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data on current use pesticides is minimal—
and in some cases completely absent—with 
most of the published literature focused on 
pesticides that are no longer registered for use.
Therefore, the aim of this study was to test 
the anti androgenic activity of currently used 
pesticides, with a view to informing future 
studies to determine their likely role in caus-
ing TDS. We selected compounds for test-
ing based on evidence of human exposure 
(dietary intake data for Europe) and predicted 
AR antagonism according to the quantita-
tive structure–activity relationship (QSAR) 
model developed by Vinggaard et al. (2008). 
Compounds predicted to be AR antagonists 
and compounds with high exposure scores 
were analyzed for AR antagonist proper-
ties using the MDA-kb2 assay (Ermler et al. 
2010; Wilson et al. 2002). In addition, we 
used the yeast anti androgen screen (YAS) to 
further test a subset of pesticides that were 
newly identified as AR antagonists or that had 
MDA-kb2 assay results that were discordant 
with QSAR predictions.
Materials and Methods
Test compound selection. Pesticides were 
selected using a combination of exposure 
scores and data about receptor-mediated anti-
androgenic activity [see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002895)]. First, 
we identified 134 pesticides with data sug-
gesting relevant human exposures, including 
58 pesticides identified at the highest con-
centrations and most frequently in European 
foods (European Commission 2008); 30 addi-
tional pesticides with relatively high daily 
dietary intakes (> 0.0004 μg/kg/day) identified 
by the FAO/WHO (Food and Agriculture 
Organization of the United Nations/World 
Health Organization) Joint Meeting on 
Pesticide Residues (JMPR) (FAO/WHO 
2011); 44 additional pesticides identified in 
> 0.4% of fruits and vege tables during rou-
tine testing [European Food Safety Authority 
(EFSA) 2009]; and o,p´- and p,p´‑DDE, which 
we included because of known adipose tissue 
levels (Fernández et al. 2004). Each pesticide 
was assigned four scores, with each ranging 
from 1 to 10: a) maximum food residue level 
(European Commission 2008); b) estimated 
daily dietary intake (FAO/WHO 2011); c) fre-
quency of detection in fruits and vegetables 
(EFSA 2009), with a score of 5 assigned when 
data were not available; and d) a score accord-
ing to the number of times pesticides were 
listed as one of the top 10 pesticides identified 
in fruits and cereals in Europe (a frequency 
score), with a score of 0 assigned if they were 
never listed (European Commission 2008). 
The four scores were summed to generate a 
“total exposure score,” with a maximum pos-
sible score of 40 (see Supplemental Material, 
Table 1).
The second stage of compound selec-
tion for testing was an assessment of in vitro 
evidence of AR inter action in the available 
litera ture (Andersen et al. 2002; Bauer et al. 
2002; Kojima et al. 2004; Okubo et al. 2004; 
Orton et al. 2009; Vinggaard et al. 2008). 
Compounds previously shown not to be AR 
antagonists in vitro (n = 43) were removed 
from the list, which reduced the num-
ber of candidate pesticides from 134 to 91. 
Compounds previously reported to be AR 
antagonists (n = 27) were removed if the ratio 
of their total exposure score to their published 
IC20 [concentration that inhibits the androge-
nicity of DHT by 20%; total exposure score/
published IC20 = “environ mental relevance 
ratio” (ERR)] was < 3 (ERR was recalculated 
using our experimental data after the selec-
tion process). This left 14 previously reported 
AR antagonists for testing by the MDA-kb2 
assay. For pesticides without published data 
(n = 64), AR antagonist activity was predicted 
using the QSAR developed by Vinggaard et al. 
(2008). These pesticides were tested using 
the MDA-kb2 assays if they were predicted 
to have AR antagonist activity (n = 4) or if 
they had high exposure scores (> 8) regardless 
of their QSAR status, including 6 pesticides 
that were predicted not to have AR antagonist 
activity and 13 pesticides that could not be 
predicted because they were out of the domain 
of the QSAR model. In total, 37 compounds 
were selected for testing in the MDA-kb2 
assay. Finally, 8 pesticides that were newly 
described as highly active anti androgens in the 
MDA-kb2 assay and 4 pesticides for which 
the QSAR prediction differed from the experi-
mental result (including 1 out of the model 
domain) were subjected to further testing 
using the YAS (n = 14). For a summary of the 
selection process, see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.1002895).
Chemicals. Dihydrotestosterone (DHT; 
> 97% purity) was purchased from Steraloids 
Ltd. (Croydon, Surrey, UK); novaluron, 
dimethomorph, p,p´-DDE, methiocarb, and 
indoxa carb were purchased from Greyhound 
Chromatography and Allied Chemicals (all 
> 98.7% pure; Birkenhead, Merseyside, UK); 
and all other pesticides (all > 97% pure) were 
purchased from Sigma Aldrich (Poole, Dorset, 
UK). Ethanol (> 99.7% purity) was obtained 
from VWR International Ltd. (Leicestershire, 
UK). All test compounds were dissolved in 
ethanol to make stock solutions to be used in 
the assays.
MDA-kb2 assay. MDA-kb2 cells are human 
breast cancer cells stably transfected with a fire-
fly luciferase reporter gene that is driven by 
an androgen-response element–containing 
promoter (Wilson et al. 2002). Details of 
the modified assay were published previously 
(Ermler et al. 2010). Briefly, cells were seeded at 
a concentration of 1 × 105 cells/mL in phenol 
red–free Leibowitz-15 medium (Invitrogen 
Ltd., Paisley, UK) containing 10% (charcoal-
stripped) fetal calf serum (Invitrogen Ltd.) 
in white luminometer plates and allowed to 
attach for 24 hr. Cells were then exposed to 
eight serial dilutions of selected pesticides 
with or without DHT (0.25 nM). After 
24 hr, luciferase activity was determined with 
SteadyGlo assay reagent (Promega UK Ltd., 
Southampton, Hampshire, UK) and measured 
in a plate reader (FLUOstar Optima, BMG 
Labtech GmbH, Offenburg, Germany). The 
following controls were run on each plate: 
media, ethanol, DHT coexposure (0.25 nM), 
DHT serial dilutions (0.002–10 nM), and 
flutamide (0.013–8 μM) or procymidone 
(0.005–3.2 μM) serial dilutions. All concen-
trations were tested in duplicate over two 
plates, and each pesticide was measured at least 
twice in separate experiments. For compara-
tive purposes, luminescence was normalized 
to DHT alone at coexposure concentration 
(maximum response, 100%) and solvent-only 
(ethanol) controls (minimum response, 0%). 
Initially, flutamide was used as the internal 
quality control for anti androgenicity; however, 
because of overlap of toxic effects on the cells 
with anti androgenic activity, it was replaced 
by procymidone, which is more potent [IC50 
(50% concentration that inhibits): flut-
amide, 1.56 μM; procymidone, 0.53 μM] but 
non toxic to MDA-kb2 cells in the concentra-
tion range associated with receptor antago-
nism. Pesticides were initially tested over a 
concentration range of 0.64 nM–50 μM 
(5× dilutions) as a range-finding exercise. 
Subsequently, the concentration ranges were 
modified to reflect the potency and toxicity 
of each individual compound. Because cyto-
toxic effects could not be distinguished from 
anti androgenic effects in the coexposed treat-
ments, any readings of the pesticide statistically 
significantly below the mean ethanol control 
level (0%) were considered toxic to MDA-kb2 
cells, and the corresponding coexposure data 
were not classified as anti androgenic. Sixty 
percent of the pesticides were repeat tested 
using the same product but with new stock 
solutions and by a different experimenter.
YAS. The methods for the YAS have 
been described previously (Sohoni and 
Sumpter 1998). Briefly, stimulation of the 
transfected AR causes a color change in the 
media, which is measured by absorbance at 
540 nm (Labsystems Multiskan Multisoft, 
Vienna, VA, USA). Plates were also measured 
at 620 nm to measure cell growth (turbid-
ity) to check for any cyto toxic effects that 
may have occurred. Pesticides were coincu-
bated with DHT (6.4 nM). Controls run in 
each experi ment were ethanol, DHT serial 
dilutions (0.0026–100 nM), and flutamide 
serial dilutions (0.19–100 μM). The pesti-
cide concentration range varied according to 
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potency observed in MDA-kb2 assay but was 
between 0.016 and 750 μM for all test com-
pounds. Incubation time was 53 hr at 28°C. 
Where turbidity readings were significantly 
depressed, toxicity was indicated and the 
effect could not be considered anti androgenic; 
therefore, these dilutions were removed from 
analysis. Pesticide serial dilutions were tested 
in duplicate over two plates and were tested 
in two separate experiments.
Statistics. To analyze anti androgenic 
action, raw luminescence readings were 
normalized on a plate-by-plate basis to the 
means of the positive DHT controls (n = 8) 
and the solvent controls (n = 8) (Ermler 
et al. 2010). We pooled all data from the 
same test compound and conducted statisti-
cal  concentration–response regression analy-
ses using the best-fit approach (Scholze et al. 
2001). Specifically, a variety of non linear 
regression models were fitted independently to 
the same data set, and the best-fitting model 
was selected using a statistical goodness-of-fit 
criterion. Concentration–response data from 
different researchers were first analyzed one by 
one using regression models, and differences 
in regression analyses due to data from dif-
ferent researchers were judged as statistically 
significant when the 95% CIs of the regression 
curves did not overlap. Such statistical differ-
ences between researchers were not observed, 
and thus data were pooled for final analysis. 
Luminescence readings from pesticides tested 
in the absence of DHT were divided by the 
mean of the solvent controls from the same 
plate and analyzed for negative and positive 
trends (suggestive of cytotoxic or androgenic 
action, respectively) by non parametric contrast 
tests (Neuhaeuser et al. 2000). Data consid-
ered to be statistically significant at p < 0.05 
were analyzed using the best-fit approach as 
described above. All statistical analysis was 
performed using SAS statistical software (SAS 
Institute Inc., Cary, NC, USA). From the 
best-fitting model, we derived inhibitory con-
centrations for anti androgenicity and effect 
concentrations for cytotoxicity.
Results
We derived the within-plate variation from 
readings of the positive DHT controls as a 
coefficient of variation (CV), with 95% of 
all CVs falling between 2.1% and 12.9% 
(mean, 6.5%). Of the 37 tested com-
pounds, 24 pesticides were anti androgenic 
in the MDA-kb2 assay, 9 of which are 
newly described (Table 1, Figure 1). The 
most potent in vitro AR antagonist was feni-
trothion (IC20 = 0.098 μM), and the least 
potent was pyrimethanil (IC20 = 27.2 μM). 
Table 1. Receptor-mediated anti androgenic activity and cytotoxicity in the MDA-kb2 and YAS assays.
Antiandrogen IC20 (μM) Cytotoxic EC20 (μM) Androgenc EC20 (μM) 
MDA-kb2Compound Expirationa Scoreb QSAR prediction MDA-kb2 YAS MDA-kb2 YAS ERR
Fungicides
Cyprodinild Apr 2017 33 Inactive 15.1 1.34 > 50 27.8 1.91 2.2
Procymidonee Jun 2008 33 AA 0.163 0.956 > 50 > 160 Neg 202.5
Imazalil Dec 2011 32 AA 3.23 — 19.0 — Neg 9.9
Pyrimethanild May 2017 28 Inactive 27.2 9.15 > 125 167 27.8 1.0
Fludioxonild Oct 2018 25 OD 0.801 0.730 28.5 > 160 Neg 31.2
Azoxystrobin Dec 2011 24 Inactive Neg — 2.9 — Neg NA
Fenhexamidd May 2011 24 Active 2.02 — 21.6 — Neg 11.9
Tolylfluanid Sep 2016 24 OD Neg 0.234 8.09 1.14 Neg NA
O-Phenylphenol Dec 2019 21 AA 3.43 — > 50 — Neg 6.1
Prochloraze Dec 2010 18 AA 2.39 — 12.5 — Neg 7.5
Pyraclostrobin May 2014 17 OD Neg — 0.089 — Neg NA
Mandipropamid Jul 2011 18 OD Neg — 8.92 — Neg NA
Tebuconazole Aug 2019 16 AA 2.89 — 38.9 — Neg 5.5
Difenoconazole Dec 2018 13 Active Neg Neg 2.91 0.109 Neg NA
Vinclozoline Jan 2007 13 AA 0.163 — > 50 — 2.9 79.8
Dimethomorphd Sep 2017 12 Active 0.263 38.5 > 25 > 50 Neg 45.6
Quinoxyfend Aug 2014 12 Inactive 4.79 1.21 10.1 > 75 Neg 2.5
Spiroxamine Dec 2011 9 OD Neg — 9.29 — Neg NA
Ethoxyquine Mar 2008 8 AA 10.7 11.1 > 50 > 200 Neg 0.75
Insecticides
Pirimiphos-methyld Sep 2017 30 OD 5.49 3.08 > 50 > 200 Neg 5.5
Endosulfane Jun 2006 19 AA 6.05 — 33.8 — Neg 3.1
Methiocarb Sep 2017 17 AA 6.82 — > 46 — Neg 2.5
Spirotetramat Pending 17 OD Neg — > 50 — Neg NA
Azinphos-methyld,e Jan 2007 16 OD 5.38 2.25 33.9 > 150 Neg 2.9
Bifenthrine May 2010 16 Active Neg 99.8 22.2 > 200 Neg NA
Indoxacarb Mar 2016 16 OD Neg — 11.3 — Neg NA
Spinosad Jan 2017 16 OD Neg — 13.1 — Neg NA
λ-Cyhalothrind Dec 2011 15 Inactive 23.1 95.4 51.4 > 200 Neg 0.65
Dicofole Mar 2009 15 AA 1.43 — 29.0 — Neg 10.5
Bromopropylatee Jul 2007 13 AA 0.540 — 27.2 — Neg 24.1
Propargitee Dec 2010 13 OD Neg — 0.487 — Neg NA
Fenitrothione Nov 2007 11 AA 0.098 — > 50 — 4.9 112.2
Novaluron Jul 2011 9 OD Neg — > 50 — Neg NA
Profenofose Jul 2003 8 OD Neg — 8.61 — Neg NA
p,p´-DDEe 1986 —f AA 0.948 — > 50 — 3.6 NA
Herbicides
Chlorpropham Jan 2015 22 Inactive 7.66 10.2 > 50 > 40 2.67 2.9
Linuron Dec 2013 12 AA 1.74 — > 50 — 3.48 6.9
Abbreviations: AA, antiandrogenic, refers to known antiandrogens (not assessed by QSAR); EC20, concentration that produces a 20% effect; IC20, concentration that inhibits the androge-
nicity of DHT by 20%; NA, not applicable; Neg, no response was observed; OD, out of domain (QSAR was not able to predict activity for this compound).
aExpiration date is taken from Annex 1 of Council Directive 91/414/EEC concerning the “placing of plant protection products on the market” (European Union 1991). bFor details of 
exposure score, see text and Supplemental Material, Tables 1 and 2 (doi:10.1289/ehp.1002895). cAndrogenic in the absence of DHT. dA newly described anti androgenic compound. eThe 
expiration date is in the past, so the compound can no longer be used in Europe. fNot included in ranked exposure. 
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Figure 1. Results of the MDA-kb2 assay showing regression curves for anti androgenic pesticides (A–D) and stimulatory activity for chlorpropham (E) and 
cyprodinil (F). Values for luminescence were normalized to those of controls. In A–D, compounds are grouped by exposure scores (see Table 1), from highest (A) 
to lowest (D), with procymidone shown in each as a point of reference. Regression lines end at the toxic threshold. Dashed lines indicate pesticides with lapsed 
registration, and solid lines indicate pesticides with current registration; data shown are mean ± SE. Data for chloropham (E) and cyprodinil (F) demonstrate overlap 
of AR antagonism (black data points and curves) with receptor agonism (gray curves). 
aNewly described anti androgens. 
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All 14 compounds previously reported in the 
literature as anti androgenic were confirmed 
using our test system. Two of 4 previously 
untested pesticides that were predicted to be 
AR antagonists in the QSAR were positive in 
the MDA-kb2 assay, and 3 of 13 pesticides 
that could not be predicted using the QSAR 
(i.e., they were out of the model domain) 
were also anti androgenic. Five of 6 pesticides 
predicted to be inactive based on the QSAR 
were AR antagonists in the MDA-kb2 assay, 
but 3 were out of the QSAR prediction range 
because they were anti androgenic at a concen-
tration higher than the exclusion criterion of 
the QSAR (limit of detection, IC25 ≤ 10 μM; 
IC20: cyprodinil, 15.1 μM; pyrimetha-
nil, 27.2 μM; cyhalothrin, 23.1 μM).
All 14 pesticides tested using the YAS 
were anti androgenic, including two that 
lacked activity in the MDA-kb2 assay [tolyl-
fluanid (out of domain of QSAR) and bifen-
thrin (predicted active in QSAR)] (Table 1).
Twenty-two of the 37 pesticides ana-
lyzed in the MDA-kb2 assay were cytotoxic. 
The concentrations required to elicit cyto-
toxicity were between 2.1 times (quinoxy-
fen) and 50 times (bromopropylate) higher 
than the concentrations associated with anti-
androgenicity [based on the ratio of EC20 
(concentration that produces a 20% effect) for 
cytotoxicity and IC20 for anti androgenicity]. 
Seven of the chemicals analyzed in the MDA-
kb2 assay showed AR agonist activity when 
tested in the absence of DHT coexposure, 
including two (cyprodinil and chlorpropham) 
with androgenic activity occurring at lower 
concentrations than anti androgenic activ-
ity (Table 1, Figure 1). Four of 14 pesticides 
were cytotoxic in the YAS assay (cyprodinil, 
pyrimethanil, tolylfluanid, and difenocon-
azole), whereas we observed no AR agonism 
in this assay (Table 1).
Discussion
Our results indicate that systematic testing 
for anti androgenic activity of currently used 
pesticides is urgently required. For example, 
20 of the 50 pesticides with the highest expo-
sure scores were anti androgenic in at least 
one assay, including 8 that have not been 
identified as anti androgens previously [see 
Supplemental Material, Figure 2 (doi:10.1289/
ehp.1002895)]. In previous in vitro screen-
ings of current-use pesticides, proportions of 
anti androgenic pesticides were broadly similar 
[32% (52 of 161), Kojima et al. 2004; 50% 
(6 of 12), Orton et al. 2009; 62% (38 of 61), 
Vinggaard et al. 2008], further supporting 
the possibility that a large fraction of untested 
pesticides may be anti androgenic. In contrast, 
estrogenic activity appears to be less common 
in current-use pesticides [18% (29 of 161), 
Kojima et al. 2004; 0% (0 of 100), Nishihara 
et al. 2000; 0% (0 of 12), Orton et al. 2009]. 
Some discrepancy between our data and pub-
lished data exists; for example, pirimiphos-
methyl was previously reported to have no 
anti androgenic activity (Kojima et al. 2004), 
and chlorpropham has been reported to have 
no activity (Kojima et al. 2004) and to be anti-
androgenic (Orton et al. 2009). These differ-
ences are most likely due to differences among 
the assay systems used. We also observed differ-
ences between findings based on the MDA-kb2 
assay and the YAS assay. However, IC20 values 
based on the two assays never deviated by more 
than one order of magnitude, with the excep-
tion of two pesticides (tolylfluanid, bifenthrin) 
that were cyto toxic in the MDA-kb2 assay, and 
dimethomorph, for which we observed a large 
divergence in AR antagonist activity (IC20: 
MDA-kb2, 0.263 μM; YAS, 38.5 μM).
We did not design our study to evaluate 
the QSAR by Vinggaard et al. (2008), and 
the number of chemicals falling within the 
applicability domain of the model was low; 
however, we note that several pesticides with 
anti androgenic activity in vitro were not pre-
dicted by the QSAR, in part because some of 
the compounds were less potent than the pre-
diction domain of the QSAR, which classifies 
chemicals with an IC25 > 10 μM as devoid 
of anti androgenicity. The large percentage of 
pesticides for which the QSAR was not able 
to provide predictions (45 of 64) suggests that 
extending the applicability domain would 
increase the usefulness of the model.
The ranking according to our expo-
sure scoring system was similar to the listed 
“adjusted theoretical maximum dietary intake” 
of pesticides (58% concordance among the 
top 40 compounds) previously reported by 
Menard et al. (2008), which is based on actual 
French consumption data and maximum resi-
due levels. Consequently, the ERR was similar, 
using either our exposure scores or the adjusted 
theoretical dietary intake published by Menard 
et al. (2008) [see Supplemental Material, 
Table 2 (doi:10.1289/ehp.1002895)]. Both our 
exposure data and those used by Menard et al. 
(2008) were sourced from before 2008 (except 
JMPR reports from 2008 and 2009) and there-
fore may not be fully representative of current 
exposures. Indeed, from 2005 through 2010, 
the authorizations for use granted by European 
Union authorities expired for 12 of the tested 
pesticides, including several in vitro AR antago-
nists (procymidone, prochloraz, vinclozolin, 
ethoxyquin, endosulfan, azinphos-methyl, 
bromo propylate, dicofol, and fenitrothion) and 
3 without evidence of anti androgenic activity 
(bifenthrin, propargite, and profenofos). Thus, 
exposure to some of the tested compounds 
should decrease, whereas exposure to replace-
ment products may increase. For example, a 
pesticide formulation called Switch, which con-
tains cyprodinil and fludioxonil (both of which 
were anti androgenic in our test system), was 
recommended as a replacement for the vinclo-
zolin formulation Ronilan (Shah et al. 2002).
To our knowledge, except for two reports 
to date (Heudorf and Angerer 2001; Saieva 
et al. 2004), there is a complete absence of 
published human biomonitoring data for pes-
ticides in Europe, and therefore, it is impos-
sible to predict how the levels eliciting an 
effect in vitro may correspond to human inter-
nal concentrations. Similarly, although the 
National Health and Nutrition Examination 
Survey (NHANES) in the United States 
incorporates human biomonitoring of pesti-
cides, exposure concentrations in human tar-
get tissues are very poorly understood, because 
of the almost complete lack of toxico kinetic 
data, short half-lives of current use pesticides, 
unspecific urinary metabolites, and unknown 
metabolic pathways (see Barr 2008). Pesticides 
with rela tively large ERRs, including dimetho-
morph (expiration of European Union 
authorization, September 2017), fludioxonil 
(October 2018), fenhexamid (May 2011), 
imazalil (December 2011), linuron (December 
2013), ortho-phenylphenol (December 2019), 
tebuconazole (August 2019), and pirimiphos-
methyl (September 2017), may be important 
anti androgenic pollutants at present and in the 
future (Table 1). Linuron and tebuconazole 
are known in vivo anti androgens (Lambright 
et al. 2000; Taxvig et al. 2007); however, data 
on the other pesticides are much more lim-
ited. This is especially true of dimethomorph, 
fludioxonil, and fenhexamid, for which we 
were unable to identify previous publica-
tions regarding endocrine disruption. These 
compounds are newly formulated fungicides 
(dimethomorph, 2007; fludioxonil, 2008; 
fenhexamid, 2001), which are stable on food 
commodities (> 70% of the parent com-
pound) and remain unchanged on the com-
modity when reaching the consumer (EFSA 
2007, 2010a, 2010b). Dimethomorph and 
fenhexamid belong to the fungicide group of 
sterol bio synthesis inhibitors (Leroux 2004), as 
do the in vivo anti androgenic conazoles (e.g., 
Taxvig et al. 2007) and imidazoles (Vinggaard 
et al. 2005). A study of the sterol biosynthesis 
inhibitors imazalil, propi conazole, triadime-
fon, triadimenol, and prochloraz indicated 
that all inhibited aromatase in human placen-
tal microsomes (Vinggaard et al. 2000), but to 
our knowledge, effects of dimethomorph and 
fenhexamid on steroido genesis in mammalian 
cells have not been assessed. Imazalil and the 
in vivo anti androgen prochloraz (Vinggaard 
et al. 2005) are both classified as imidazole 
fungicides, and in vitro potency estimates 
for the two compounds were similar (IC20: 
imazalil, 3.23 μM; prochloraz, 2.39 μM), but 
the possible effects of imazalil in vivo have not 
been evaluated. Therefore, it is our view that 
dimethomorph, fludioxonil, fenhexamid, and 
imazalil should be tested in vivo as a matter 
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of urgency. Another rele vant pesticide may 
also be ortho-phenyl phenol, which is used as a 
fungicide in agriculture and as a wood preser-
vative, and also has a wide variety of industrial 
applications (e.g., preserva tion of glues, plastic 
additives in flame retardants, disinfectant in 
hospitals) (LANXESS Corp. 2010). In our 
exposure ranking system, it ranked 12th out 
of 37 test compounds (Table 1). Considering 
that ortho-phenyl phenol was highly ranked 
by exposure and that non agricultural sources 
were absent from our exposure scores, it is not 
surprising that it was detected in all human 
urine samples tested in two studies [mean 
concentration, 2.9 nM, n = 30 samples (Ye 
et al. 2005); 35.2 nM, n = 22 samples (Bartels 
et al. 1997)], 85% of breast milk samples 
[mean concentration, 10.6 nM, n = 20 sam-
ples (Ye et al. 2006)], and 30% of amniotic 
fluid samples [mean concentration, 0.76 nM, 
n = 20 samples (Bradman et al. 2003)] in 
the United States. ortho-Phenyl phenol was 
previously identified as a receptor-mediated 
anti androgen (Kojima et al. 2004), but no 
data are available on its possible effects in vivo. 
Pirimiphos-methyl is an organothiophos-
phate insecticide that is stable on stored grain 
(< 24 weeks, 70% unchanged parent com-
pound; EFSA 2005). There are also indica-
tions that it may be anti androgenic in vivo 
because maternal and post natal exposure of 
rats to 12 mg/kg body weight/day caused tes-
ticular tubular atrophy (EFSA 2005). In addi-
tion, treatment of adult male rats for 90 days 
resulted in decreased sperm density and mobil-
ity (125 mg/kg body weight/day), testicular 
atrophy (lowest observed adverse effect level, 
41.67 mg/kg body weight/day), and decreased 
fertility (125 mg/kg body weight/day) (Ngoula 
et al. 2007). There is insufficient evidence to 
assess the risk of tested pesticides to human 
health because of a lack of data. However, to 
our knowledge, all of the pesticides (with the 
possible exception of fenitrothion; Okahashi 
et al. 2005; Turner et al. 2002) identified as 
in vitro AR antagonists in our study have also 
been reported to have anti androgenic effects 
in vivo in animal models (Anway et al. 2006; 
Gray et al. 1999; Lambright et al. 2000; 
McIntyre et al. 2002; Ostby et al. 1999; Sinha 
et al. 2001; Taxvig et al. 2007; Uzumcu et al. 
2004; Vinggaard et al. 2005). We also identi-
fied 7 compounds that appeared to be andro-
genic because they stimulated activity in the 
absence of DHT. The mechanism of action 
for this response is not well characterized; 
however, it has been previously detected in 
this assay (Tamura et al. 2006; Wilson et al. 
2002) and was proposed to be due to confor-
mational change of the ligand-binding pocket 
in such a way that simultaneous androgenic 
and anti androgenic activities were possible 
(Tamura et al. 2006). We are unable to con-
firm or reject these data; however, preliminary 
data from our laboratory suggests that the 
stimulatory response is neither via stimulation 
of the receptor, because we have not observed 
evidence of androgenic effects in the YAS for 
any compounds, nor due to cell proliferation, 
as evidenced by transient transfection of cells 
with a non androgenic responsive element. 
Cyprodinil and chlorpropham were more 
potent AR agonists (EC20 = 1.91 and 2.67, 
respectively) than antagonists (IC20 = 15.1 and 
7.66, respectively) in the MDA-kb2 assay.
Conclusions
In addition to identifying new candidate anti-
androgens, our findings highlight important 
data gaps that prevent accurate assessment of 
male reproductive health risks from pesticides. 
The most important of these are the absence 
of in vivo studies and human biomonitoring 
data for environmentally rele vant pesticides. 
In addition, fungicides typically had high 
exposure scores and were thus well represented 
in the testing set, presumably because they are 
often applied just before or after harvest to 
food commodities. They are typically applied 
as mixtures in order to increase effectiveness 
and prevent development of resistant strains 
(Fungicide Resistance Action Committee 
2010), and therefore, human exposure to 
mixtures of these in vitro anti androgens may 
be considerable. The contribution of pesti-
cides to declining male reproductive health 
requires further investigation, particularly to 
clarify the relationship between effective con-
centrations in vivo and exposure.
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